OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Alternative splicing: a bridge connecting NAFLD and HCC
Kequan Xu, Tiangen Wu, Peng Xia, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 10, pp. 859-872
Open Access | Times Cited: 13
Kequan Xu, Tiangen Wu, Peng Xia, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 10, pp. 859-872
Open Access | Times Cited: 13
Showing 13 citing articles:
Lipid Metabolism as a Potential Target of Liver Cancer
Kangze Wu, Feizhuan Lin
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 327-346
Open Access | Times Cited: 5
Kangze Wu, Feizhuan Lin
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 327-346
Open Access | Times Cited: 5
Unveiling the role of disulfidptosis-related genes in the pathogenesis of non-alcoholic fatty liver disease
Xiaohua Luo, Junjie Guo, Hongbo Deng, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Xiaohua Luo, Junjie Guo, Hongbo Deng, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Downregulation of hnRNPA1 inhibits hepatocellular carcinoma cell progression by modulating alternative splicing of ZNF207 exon 9
Qi Ouyang, Wenhui He, Yiping Guo, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Qi Ouyang, Wenhui He, Yiping Guo, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Bulk transcriptome and single-nucleus RNA sequencing analyses highlight the role of recombination activating 1 in non-alcoholic fatty liver disease
Xiaohua Luo, Hongbo Deng, Qiang Li, et al.
International Journal of Biological Macromolecules (2025) Vol. 307, pp. 141919-141919
Closed Access
Xiaohua Luo, Hongbo Deng, Qiang Li, et al.
International Journal of Biological Macromolecules (2025) Vol. 307, pp. 141919-141919
Closed Access
Machine learning-based integration reveals reliable biomarkers and potential mechanisms of NASH progression to fibrosis
Jiahui Feng, Zheng Gong, Jia‐Ling Yang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Jiahui Feng, Zheng Gong, Jia‐Ling Yang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Analysis and identification of PTBP2 as an oncogene in hepatocellular carcinoma
Yuxuan Li, Fengguang Zhai, Lili Kong, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Yuxuan Li, Fengguang Zhai, Lili Kong, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
SF3B4 regulates proliferation and apoptosis in hepatocellular carcinoma via alternative splicing and interaction with TRIM28 and SETD5
Hanfei Huang, Yuan Fang, ZhiTao Li, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Hanfei Huang, Yuan Fang, ZhiTao Li, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Machine learning-based prognostic modelling of NK cells in PAAD for immunotherapy guidance
Li Li, Wu Zz, Wanxing Duan, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Li Li, Wu Zz, Wanxing Duan, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
B-cell-specific signatures reveal novel immunophenotyping and therapeutic targets for hepatocellular carcinoma
Kequan Xu, Zheng Gong, Jia‐Ling Yang, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 34, pp. 3894-3925
Closed Access | Times Cited: 2
Kequan Xu, Zheng Gong, Jia‐Ling Yang, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 34, pp. 3894-3925
Closed Access | Times Cited: 2
NRDE2 deficiency impairs homologous recombination repair and sensitizes hepatocellular carcinoma to PARP inhibitors
Yahui Wang, Xinyi Liu, Xianbo Zuo, et al.
Cell Genomics (2024) Vol. 4, Iss. 5, pp. 100550-100550
Open Access | Times Cited: 1
Yahui Wang, Xinyi Liu, Xianbo Zuo, et al.
Cell Genomics (2024) Vol. 4, Iss. 5, pp. 100550-100550
Open Access | Times Cited: 1
The Role of RNA Splicing in Liver Function and Disease: A Focus on Metabolic Dysfunction-Associated Steatotic Liver Disease
Dorota Kamińska
Genes (2024) Vol. 15, Iss. 9, pp. 1181-1181
Open Access | Times Cited: 1
Dorota Kamińska
Genes (2024) Vol. 15, Iss. 9, pp. 1181-1181
Open Access | Times Cited: 1
Deciphering the Divergent Gene Expression Landscapes of m6A/m5C/m1A Methylation Regulators in Hepatocellular Carcinoma Through Single-Cell and Bulk RNA Transcriptomic Analysis
Hang-Tsung Liu, Cheng‐Shyuan Rau, Yueh‐Wei Liu, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 2383-2395
Open Access | Times Cited: 3
Hang-Tsung Liu, Cheng‐Shyuan Rau, Yueh‐Wei Liu, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 2383-2395
Open Access | Times Cited: 3
Expression of SRP14 in hepatocellular carcinoma and its relationship with disease progression and patient survival
Huimin Tian, Dongmei Tang, Meilin Ma, et al.
Journal of Zhejiang University (Medical Sciences) (2024) Vol. 53, Iss. 4, pp. 460-471
Open Access
Huimin Tian, Dongmei Tang, Meilin Ma, et al.
Journal of Zhejiang University (Medical Sciences) (2024) Vol. 53, Iss. 4, pp. 460-471
Open Access
Prognostic alternative splicing and multi-omics characteristics reveal FTCD is a potential target of hepatocellular carcinoma
Yanli Zhang, Wenxing Li, Mengyi Sun, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
Yanli Zhang, Wenxing Li, Mengyi Sun, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
Perturbation of mRNA splicing in liver cancer: insights, opportunities and challenges
Qi Jia, Xiaoxiao Sun, Haoyu Li, et al.
Gut (2024), pp. gutjnl-333127
Closed Access
Qi Jia, Xiaoxiao Sun, Haoyu Li, et al.
Gut (2024), pp. gutjnl-333127
Closed Access
